9h-xanthene-9-carboxylic acid [1,2,4]oxadiazol-3-yl- and (2h-tetrazol-5-yl)-amides as potent, orally...

1
2005 Receptor binding activity X 0280 9H-Xanthene-9-carboxylic Acid [1,2,4]Oxadiazol-3-yl- and (2H-Tetra- zol-5-yl)-amides as Potent, Orally Available mGlu1 Receptor Enhancers. — A novel set of compounds such as (I) and (II) is synthesized. The structure—activity re- lationships are discussed in detail. (Ia) could serve as a suitable tool to further study the role of positive allosteric modulation of mGlu1 receptor in vivo. — (VIEIRA*, E.; HUWYLER, J.; JOLIDON, S.; KNOFLACH, F.; MUTEL, V.; WICHMANN, J.; Bioorg. Med. Chem. Lett. 15 (2005) 20, 4628-4631; Pharma Res., F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switz.; Eng.) — K. Schneider 02- 220

Upload: eric-vieira

Post on 06-Jun-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

2005

Receptor binding activityX 0280 9H-Xanthene-9-carboxylic Acid [1,2,4]Oxadiazol-3-yl- and (2H-Tetra-

zol-5-yl)-amides as Potent, Orally Available mGlu1 Receptor Enhancers. — A novel set of compounds such as (I) and (II) is synthesized. The structure—activity re-lationships are discussed in detail. (Ia) could serve as a suitable tool to further study the role of positive allosteric modulation of mGlu1 receptor in vivo. — (VIEIRA*, E.; HUWYLER, J.; JOLIDON, S.; KNOFLACH, F.; MUTEL, V.; WICHMANN, J.; Bioorg. Med. Chem. Lett. 15 (2005) 20, 4628-4631; Pharma Res., F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switz.; Eng.) — K. Schneider

02- 220